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Abstract. Human autoantibodies offer unique tools for 
the study of cellular constituents since they usually 
recognize highly conserved components, the most 
difficult to detect due to their low immunogenicity. 
The serum from a patient with Sj6gren's syndrome 
(RM serum) showing a very high reactivity to the 
Golgi complex has been shown to immunoprecipitate 
and to immunodetect by Western blotting experiments 
a protein of mol wt 210,000 (p210) that was shown to 
be peripheral and cytoplasmically disposed. A close 
examination of the p210 labeling revealed some differ- 
ences with Golgi markers: RM serum staining was 
slightly more extensive than several Golgi markers and 
showed a discontinuous or granular appearance. 
Nocodazole induced a specific and early segregation of 
many p210-associated vesicles or tubules from Golgi 
apparatus. Upon brefeldin A treatment, p210 did not 
redistribute in the ER as did other Golgi proteins. In 
contrast, it exhibited a vesicular pattern reminiscent to 
that displayed by proteins residing in the intermediate 
compartment. Double staining immunofluorescence 
using the RM serum and the marker of the intermedi- 
ate compartment, p58, revealed segregation of both 
proteins in control conditions but colocalization in 
BFA-treated cells. We have further demonstrated by 
combining different drug treatments that p210- 
containing elements in brefeldin A-treated cells belong 
indeed to the intermediate compartment. Experiments 
on brefeldin A recovery suggested that these p210 ele- 
ments might play a role in reformation and reposition- 
ing of the Golgi apparatus. Ultrastructural localization 
performed by immunoperoxidase staining allowed us 
to establish that p210 interacted with the external side 
of an abundant tubulo-vesicular system on the cis side 
of the Golgi complex which extended to connecting 
structures and vesicles between saccules or stacks of 
cisternae, p210 appears to be a novel protein residing 
in the cis-Golgi network that may cycle between the 
Golgi apparatus and the intermediate compartment. 
T 
HE Golgi apparatus (GA) t is a dynamic membranous 
network which plays a key role in processing, matura- 
tion, and sorting of the newly synthesized proteins 
destined to specific membrane domains, or to secretion, and 
in recycling of receptors involved in endocytosis. Whereas 
ER is usually extended throughout the cytoplasm, the Golgi 
complex appears centrally located in close proximity to the 
microtubule-organizing center (Farquhar and Palade, 1981; 
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Kupfer et al., 1982). This pericentrosomal organization that 
is generated and maintained by microtubules (Wehland and 
Willingham, 1983; Wehland et al., 1983; Rogalsld and 
Singer, 1984; Sandoval et al., 1984) enables the Golgi com- 
plex to receive and to direct both exocytic and endocytic ma- 
terial that traffic through it. 
Functional and morphological studies have shown a polar- 
ized organization of the Golgi complex. A three compart- 
ment subdivision of the Golgi complex is thought to be re- 
quired to accomplish all of its functions: the cis-Golgi 
network (CGN) next to the ER, where newly synthesized 
material is received and sorted, the medial Golgi (containing 
the cis, medial, and tmns cisternae) where glycosylation and 
trimming of carbohydrate moieties takes place, and the 
trans-Golgi network (TGN) that mediates the sorting and 
exit of material from the GA before a final vesicular trans- 
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port step to the terminal destination (Mellman and Simons, 
1992). 
Transport events through the GA are thought to occur by 
movement of carrier vesicles (Palade, 1975). Nonclathrin- 
coated vesicles have been proposed to mediate transport 
from ER to the Golgi complex and between the different 
Golgi compartments (Orci et al., 1986; Maihotra et al., 
1989; Serafini et al., 1991a). The coat of these vesicles com- 
prises a set of four proteins named COPs (or, /~, 3' and 
t$-COPs) and probably two additional subunits of 20 and 36 
kD (Serafini et ai., 1991a). All of these proteins exist in a 
cytosolic complex, the coatomer, that may represent an un- 
assembled precursor of the coat (Waters et al., 1991). In ad- 
dition ADP-ribosylation factor (ARF), a small GTP-binding 
protein, has been identified as a component of the Golgi- 
derived coated vesicles (Serafini et al., 1991b). Both the 
coatomer and ARF associate reversibly to Golgi membranes 
(Donaldson et ai., 1991a; Serafini et al., 1991b) and dy- 
namics of this cycle is now well established (Donaldson et 
al., 1992a). Recently, a Golgi membrane enzyme has been 
identified which might determine the localization of mem- 
brane-bound ARF-GTP and hence the sites for vesicle bud- 
ding (Donaldson et al., 1992b; Helms and Rothman, 1992). 
Other small GTP-binding proteins of the rab family have also 
been found in association with specific vesicles and orga- 
nelles and are thought to have a crucial role in the targeting 
of vesicles to, and their fusion with, the appropriate acceptor 
organelles (Bourne, 1988; Goud and McCaffrey, 1991; Pfef- 
fer, 1992). For many of them however, more conclusive in- 
formation is still required to decide whether their localiza- 
tion is restricted to a single pair of donor-acceptor compart- 
ments (see Antony et al., 1992). Heterotrimeric G proteins 
have also been reported to be part of the transport machinery 
(Ercolani et al., 1990; Barr et al., 1991; Donaldson et al., 
1991b; Stow et ai., 1991; Ktistakis et ai., 1992). 
Various drugs proved to be useful to elucidate the dynamic 
equilibrium on which Golgi membrane organization is 
based. The fungal metabolite brefeldin A (BFA) had been 
shown to inhibit protein secretion and dramatically disinte- 
grates the Golgi apparatus, resulting in the distribution of 
Golgi membranes (lipids and proteins) in the ER by a mecha- 
nism that requires energy and microtubules. Uncoated tu- 
bules emanating from the Golgi complex are observed rap- 
idly after addition of BFA to ceils suggesting that they are 
the structural intermediates that carry the Golgi membranes 
to the ER (for review see Klausner et ai., 1992). The im- 
mediate effect of BFA is to prevent the assembly of COPs- 
coated vesicles (Orci et al., 1991) probably by interfering 
with the association of ARF and consequently of the 
coatomer complex with Golgi membranes (Donaldson et al., 
1992a). Thus BFA would block anterograde traffic between 
ER and GA without affecting retrograde transport from GA 
to ER. Morphology and functioning of other organelles of 
the secretory pathway such as TGN or the endosomal system 
are also perturbed by BFA (Klausner et al., 1992). BFA-like 
phenotypes have been described in two different situations: 
overexpression of a human ERD-2-1ike protein (Hsu et al., 
1992) and in a mutant CHO cell line (Zuber et al. 1991). All 
of these data indicate that the Golgi apparatus exists as a 
steady state structure and that the maintenance of its in- 
tegrity requires a rigorous control of the balance between an- 
terograde and retrograde traffic from ER up to terminal GA. 
In response to BFA treatment, three different behaviors of 
Golgi proteins have been reported. Most of the Golgi pro- 
teins such as mannosidase II and IA (Lippincott-Schwartz et 
al., 1989), galactosyl-transferase (Lippincott-Schwartz et 
al., 1990), the proteins p58, p54, and p86 (Donaldson et al., 
1990), and GMPc.t.2, MG 160, and GMPtq.2, (Alcaide et 
al., 1992) redistribute to ER. ~COP (Donaldson et al., 
1990), ARF (Donaldson et al., 1991a), and a p200 (Narula 
et al., 1992) dissociate from Golgi membranes to cytosol. 
Finally p58 (Saraste and Svensson, 1991) and p53 (Lippin- 
cott-Schwartz et ai., 1990), two proteins which reside in the 
intermediate compartment, do not modify their localization 
since intermediate compartment preserves its identity in the 
presence of BFA. 
Despite this major progress in understanding the function 
and organization of the Golgi complex, many Golgi mem- 
brane proteins remain to be discovered or characterized. Re- 
cently, a new immunological approach has been used in or- 
der to identify highly conserved Golgi components which 
have shown to be the most difficult to detect using classical 
strategies, namely the screening of sera libraries from pa- 
tients with systemic autoimmune diseases (Kooy et al., 
1992). Human autoantibodies offer unique tools for the 
study of cellular components since they recognize highly 
conserved and functionally important molecules. In addi- 
tion, the autoantibodies usually react with the active sites of 
the antigen and therefore they are often capable of inhibiting 
its functional activity (Tan, 1991). By using this approach, 
we have selected a serum from a patient with Sjtgren's syn- 
drome containing high titer autoantibodies to the GA (Rios, 
R. M., M. C. Boissier, J. C. Homberg, and M. Bornens, 
manuscript submitted for publication). It recognizes a novel 
Golgi protein of 210 kD in a wide variety of cells and orga- 
nisms. Biochemical and EM investigations indicate that p210 
is a peripheral protein whose localization is restricted to the 
cis side of the Golgi complex and seems to correspond to the 
CGN. Interestingly, p210 displays an unusual behavior, com- 
pared to bona fide Golgi markers, when cells are treated with 
nocodazole or with BFA. In experiments using BFA, unlike 
most Golgi proteins, p210 does not redistribute to ER but to 
the intermediate compartment. These results suggest that 
certain Golgi proteins might be excluded from the pathway 
that redistributes Golgi membrane proteins to the ER and 
that the time course of Golgi reconstitution after BFA treat- 
ment occurs by sequential events, probably involving a sub- 
set of specific proteins. 
Materials and Methods  
Cell Culture 
The KE37 cell line of T lymphoblastic origin was grown in RPMI 1640 
medium containing 7% fetal calf serum. HeLa cells were maintained in 
DME supplemented with 10% fetal calf serum. Normal muscles were ob- 
tained from patients undergoing surgical operations. The biopsy specimens 
were collected in a sterile container containing culture medium and stored 
at 4°C. The specimens were dissociated as previously described (Tassin et 
al., 1985a). 2 mM Glutamine, 50 U/ml penicillin, and 50 #g/m streptomy- 
cin were included in all culture media. 
Antibodies 
Serum of the patient R.M. suffering from Sjtgren's syndrome (see Ro- 
driguez el al., 1982 and Blascheck et al., 1988) was aliquoted, sodium azide 
added, and then stored at -70"C. IgG fraction (10 mg/ml final concentra- 
tion) was purified from whole serum on protein A-Sepharose columns and 
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stored in 50% glycerol at -70°C. CTR 433 was obtained from a library 
of monoclonal antibodies against centrosomes isolated from human lym- 
phoblasts and has been previously characterized as a marker of the med/al 
compartment of the GA (Jasmin et al., 1989). Affinity-purified antigalac- 
tosyl transferase (GalTf) antibody was kindly provided by Dr. Eric Berger 
(Institute of Physiology, Zurich, Switzerland). Affinity-purified anti-p58 
polyclonal antibody (Saraste et al., 1987) was obtained from Dr. Jaako 
Saraste (Ludwig Institute of Cancer Research, Stockholm, Sweden). A spe- 
cific antiendoplasmic reticulum antibody (Louvard et al., 1982) was the 
kind gift of Dr. D. Louvard (Institut Pasteur, Paris, France). Anti-/~-tubulin 
antibody was purchased from Amersham Corp. (Arlington Heights, IL). 
Specific antibodies from RM serum were affinity purified on nitrocellu- 
lose strips using immunoreactive proteins from different fractions, accord- 
ing to Krolme et al. (1982). 
Immunofluorescence Microscopy 
Ceils were grown on culture-treated slides for 2 d before an experiment. 
Cells were rinsed twice with PBS and incubated in methanol at -20°C for 
6 min to simultaneously fix and permeabilize the cells. After methanol 
treatment, cells were rinsed with PBS containing 0.1% Tween 20 (PBST). 
Primary antibodies diluted in PBST containing 3 % BSA were added for 1 
h at room temperature. The cells were then rinsed with PBST three times 
to wash away unbound primary antibodies. The same incubations and wash- 
ing procedures were used for fluorescein- or rhodamine-labeled secondary 
antibodies. The cells were finally dehydrated, mounted in citifluor, exam- 
ined, and photographed with a Zeiss Axiophot microscope. For the visual- 
ization of p58, the cells were fixed for 15 min at room temperature with 3% 
paraformaldehyde in 0.1% phosphate buffer, pH 7.4, and thereafter permea- 
bilized for 15 min in PBS containing 0.1% saponin. After a rinse, the cells 
were incubated with 50 mM NI-I4C1 to inactivate free aldehyde groups and 
then processed as described above. 
Drug Treatments 
BFA was purchased from Epicentre Technologies (Madison, WI) or ob- 
tained from Sandoz Ltd. (Basel, Switzerland). It was stored at -200C as 
a stock solution of  5 rng/ml in methanol. Nocodazole was obtained from 
Sigma Chem. Co. (St. Louis, MO) and stored as a 5-mM stock solution 
in DMSO at -200C. Immediately prior to use, solutions were prepared in 
culture medium. Ceils were incubated at 37°C with 10/tM nocodazole or 
1-5 t~g/ml BFA for various periods up to 2 h. The calcium iunophore 
A23187 (Sigma Chem. Co.) was administered to cells in culture medium 
at 5/~M final concentration. Cells were incubated with A23187 for 4 h at 
37°C before fixation. 
Metabolic Labeling and lmmunoprecipitation 
Subconfluent monolayers of HeLa cells were labeled with 100-200 tzCi/ml 
of [35Slmethionine/cysteine (Trans-Label; ICN Biomedicals, Inc., Costa 
Mesa, CA) for 4 h in DMEM supplemented with 5% FCS. Cells were 
washed with ice-cold PBS and incubated with 1 ml of iysis buffer (50 mM 
Tris-HCi, pH 8.0, 150 mM NaC1, 1% Triton X-100) containing 1/1,000 
CLAP (10/~g/ml in DMSO of each chymostatin, leucopeptin, antipaln, and 
pepstatin), 1 mM PMSE and 1 ~g/rrd aprotinin for 30 min in ice with 
rocking. The cell lysate was collected and clarified by centrifugation at top 
speed in a microfuge for 5 rain at 4°C. 50 #1 of a 50% solution of protein 
A-Sepharose beads in lysis buffer were incubated with 1 or 2/~1 of either 
autoimmune serum or normal human serum for 2 h in ice with rocking, 
washed, collected by centrifugatiun, and added to 50/~1 of labeled samples. 
The mixture was rotated for 2 h at 4°C, then the protein A-Sepharose beads 
were collected and washed 5 times in lysis buffer followed by two washes 
in 50 mM Tris-HC1, pH 8.0. Proteins were released from the beads by boil- 
ing in SDS-PAGE sample buffer. 
Subcellular Fractionation 
Fractions enriched in Golgi vesicles were isolated from KE37 cells by flota- 
tion in a sucrose gradient as described in Rios et al. (1992). Prior to further 
processing, Golgi-enriched fractions were diluted by addition of several 
volumes of 10 mM Tris-HC1, pH 7.4, and protease inhibitors were added. 
The suspensions were centrifuged at 200,000 g for 2 h at 40C and pellets 
were used for subsequent experiments. 
Electrophoresis and lmmunoblot Analyses 
Proteins were separated by SDS-PAGE on 8% acrylamide gels (Laemmli, 
1970) and stained with Coomassie blue. Two-dimensional gel electrophore- 
sis of Golgi-enriched fractions was performed according to O'Farrell (1975) 
and stained with silver nitrate. One- or two-dimensional gels were elec- 
trophoretically transferred to nitrocellulose filters according to Towbin et 
al. (1979). Nitrocellulose filters were blocked for 1 h at 37°C in TBST (10 
mM Tris-HCl, pH 7.4, 150 mM NaCI, 0.1% Tween 20) containing 5% non- 
fat dry milk. Then filters were incubated for 1-2 h at 37°C in the primary 
antibody diluted in TBST, washed in the same buffer, and incubated for 45 
min at 37°C with secondary anti-rabbit or anti-human IgG antibodies con- 
jugated with either alkaline phosphatase (Promnga Corp., Madison, WI) or 
peroxidase (Catalg, San Francisco, CA). After washes, alkaline phospha- 
tase activity was revealed with 0.1 M Tris-HCl, pH 9.5, 100 mM NaCi, 
5 mM MgCI2 containing both nitroblue tetrazolium and 5-bromo-4-chioro- 
indolyl phosphate. Peroxidase activity was revealed using the ECL system 
(Amersham Corp.). 
Membrane Extraction and Washing Procedures 
Golgi vesicles (50 tzg protein) were extracted with Triton X-114 as described 
by Bordier (1981). The detergent phase was taken up directly in SDS sample 
buffer; the aqueous phase was first concentrated by precipitation with 10% 
(wt/vol) TCA. Gulgi vesicles were also washed with 1 M NaC1, 0.2 M so- 
dium carbonate, pH 11.0, or 6 M urea. After incubation for 30 rain on ice, 
the samples were centrifuged for 1 h at 200,000 g. The supernatants 
(precipitated with 10 % TCA) and pellets were processed for SDS-PAGE fol- 
lowed by immunoblotting with either autoimmune serum or anti-CralTf 
antibody. 
PermeabiUzation Experiments 
HeLa cells grown on glass slides at subconfluent densities were washed with 
PBS and buffer A (25 mM Hepes-KOH, 125 mM potassium acetate, and 
2.5 mM magnesium acetate) and then incubated for different times with 
Streptolysin O (SLO; Burroughs Wellcome, Research Triangle Park, NC) 
prepared at varying concentrations in buffer A supplemented with 1 mM 
dithiothreitol. Cold buffer A was added to SLO-treated cells to stop the per- 
meabilization process and cells were washed two times with buffer A con- 
taining 1% BSA. Permeabilized HeLa ceils were incubated with the autoim- 
mune serum diluted 1/100 in buffer A containing 1% BSA. After that, cells 
were washed, fixed in methanol at -20°C, and incubated with anti-GalTf. 
As a control, an analogous experiment was performed in which permeabi- 
lized cells were incubated with the anti-GalTf antibody before fixation and 
thereaRer with the autoimmune serum. Permeabilization using 0.5 U/ml 
SLO for 7 rain at 37°C gave the best results and was routinely used. 
Electron Microscopy 
Staining of myotubes by immunoperoxidase and processing for electron mi- 
croscopy was carried out according to Saraste et al. (1987). Briefly, cells 
were fixed in paraformaldehyde-lysine-periodate fixative for 4 h at room 
temperature, permeabilized with 0.05 % saponin, and incubated with anti- 
p210 IgG (1/100) overnight. Cells were then incubated with peroxidase- 
conjugated Fab fragments of sheep anti-human IgG for 60 min, followed 
by reaction with diaminobenzidine and Epon embedding. 
Results 
The Auto-immune RM Serum Decorates the Golgi 
Apparatus in a Veide Variety of Cells 
The serum from patient R.M., hereafter termed "RM se- 
rum; was assayed by indirect immunofluorescence in a vari- 
ety of mammalian cells (HeLa, KE37, human myoblasts, 
NRK, and CHO). In all cases, RM serum showed a very high 
reactivity to the GA. A weaker nuclear staining could also 
be observed but disappeared at higher dilution of the serum. 
An example is presented in Fig. 1 where double staining of 
HeLa cells with RM serum and with a monospecific anti- 
body directed against the trans-Golgi marker GalTf is shown 
(Fig. 1, A and B). Distributions of both antigens were virtu- 
ally identical. In human myoblasts decorated with RM se- 
rum and with the monoclonal antibody CTR433, a medial- 
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Figure 1. Immunofluorescence microscopy of methanol-fixed HeLa cells (A and B), human myoblasts (C and D) stained with RM serum 
(A and C), and the Golgi markers anti-GalTf (B) and CTR 433 (D). In both cell types, RM serum gave a strong fluorescent signal in 
the Golgi region that colocalized with those shown by the Golgi markers. No staining of the ER or the cytoplasm was detected. A more 
detailed observation (A'-D') revealed that the staining patterns displayed by RM serum (A' and C') and GaiTf (B') or CTR 433 (D') were 
not identical (compare A' and B' and C' and D'). The Golgi staining of both Golgi markers was thinner and more uniform than that of 
RM serum which appeared patchy or vesicular and sometimes larger over the Golgi area. Bar, 5 /~m. 
Golgi marker (Jasmin et al., 1989), the colocalization of 
both antigens was also apparently perfect (Fig. 1, C and D). 
Despite the low resolution of immunofluorescence micros- 
copy, a close examination of the staining patterns revealed 
some differences between Golgi markers and RM serum. 
Notably, the latter showed a rather discontinuous or granular 
appearance (see Fig. 1, A' and C'), and was often slightly 
larger than the staining obtained with Golgi markers. This 
was even more obvious for myoblasts in which the GA is 
more extended (Fig. 1, C' and D'). These observations sug- 
gested that RM serum could decorate structures tightly as- 
sociated to those defined by reference Golgi markers. 
Structures Decorated by RM Serum Are Particularly 
Sensitive to MT-disruption 
Segregation between the staining observed with RM serum 
and that obtained with Golgi markers became evident when 
cells were treated with nocodazole (Fig. 2). After short treat- 
ments of nocodazole (up to 15-30 min), the morphology of 
the GA visualized with the anti-GalTf antibody was not 
significantly modified (Fig. 2 B). By contrast, numerous 
small vesicles, or tubules, decorated by RM serum appeared 
around the GA but also outside the Golgi region (Fig. 2 A). 
By 2-3 h of nocodazole treatment, the GA had completely 
fragmented and the Golgi elements had dispersed throughout 
the cytoplasm. In these conditions, staining patterns ob- 
served with RM serum and with anti-GalTf were only par- 
tially coincident, RM serum recognizing a number of ele- 
ments that did not contain GalTf (Fig. 2, compare C and D). 
Furthermore, a detailed observation revealed that even in 
elements containing both antigens, the staining patterns were 
not identical either, RM serum decorating distinct domains 
often at the periphery of the GalTf-containing domains (see 
Fig. 2, E and F, arrows). 
From this set of experiments, we concluded that RM se- 
rum additionally decorates distinct structures closely as- 
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Figure 2. Effect of nocodazole on the distribution of RM serum autoantigen. HeLa cells were treated with 10 #M nocodazole for 15 min 
(A and B) and 180 min (C and D), fixed and double stained with autoimmune RM serum (A and C) and the anti-GalTf antibody (B and 
D). After 15 min of nocodazole treatment numerous vesicles and tubules staining with autoimmune RM serum but negative for GalTf 
began to distribute throughout the cytoplasm (A, arrows; this figure has been slightly underexposed to show the small tubules). After 3 h 
nocodazole, a number of discrete Golgi dements were observed with the anti-GalTf antibody, all of which (E, large arrows) were also 
labeled with autoimmune RM serum. Other membranous elements uniquely stained by RM serum were also apparent (E, circles with 
arrows). Note that labeling patterns of Golgi elements displayed by both antibodies were not identical, that of RM serum being again more 
extensive than the pattern produced by the anti-GalTf antibody. Bar, 5 t~m. 
sociated with the GA and highly dependent on microtubules 
for both their integrity and their association with the GA. 
R M  Serum Reacts with a Golgi-enriched 
210-kD Protein 
In order to characterize the autoantigen recognized by RM 
serum, the Triton-soluble fraction of metabolically labeled 
HeLa cells (see Materials and Methods) was used for immu- 
noprecipitation. Immune complexes were analyzed by SDS- 
PAGE and fluorography. Three major bands of 210, 130, and 
45 kD were immunoprecipitated by RM serum (Fig. 3 A, 
lane /). Several other bands were also occasionally ob- 
served. In control experiments using normal human serum 
these bands were not detected (Fig. 3 A, lane 2). A complex 
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Figure 3. Autoimmune serum recognizes a 210-kD Golgi protein. 
Immunoprecipitation and Western blotting were used to identify 
the Golgi antigen of the autoimmune serum. (A) HeLa cells were 
metabolically labeled with 35S-Trans-Label and detergent extracts 
of cells were used for immunoprecipitation. Autoimmune RM se- 
rum (AS) immunoprecipitated three major proteins of 210, 130, and 
45 kD that did not appear in immunoprecipitates using normal hu- 
man serum (NHS). (B) KE37 cells were fractionated and a Golgi- 
enriched fraction prepared by flotation in a sucrose gradient. The 
enrichment of different subcellular fractions in Golgi membranes 
was tested by Western blotting using an anti-GalTf antibody. Pro- 
teins from total homogenate (H), nuclear pellet (N), post-nuclear 
supernatant (PNS), and the Golgi-rich fraction were separated by 
SDS-PAGE, transferred to nitrocellulose filters, and assayed for 
their content in GalTf. (C) A blot with identical samples to those 
in (B) was incubated with autoimmune RM serum and bound anti- 
body was detected by chemiluminescence. Proteins of 200, 130, 
and 45 kD were the major proteins observed in homogenate, nu- 
clear pellet, or postnuclear supernatant. In Golgi-enriched frac- 
tions only a 210-kD band was recognized by autoimmune RM se- 
rum; in some experiments a lighter band with a slightly faster 
mobility was also detected. (D) The pellet obtained by high-speed 
centrifugation of the postnuclear supernatant, which was highly en- 
riched in proteins of 210 and 130 kD, as judged by Western blotting 
with RM serum and devoid of any 45-kD signal (lane/), was used 
to affinity-purify RM serum on individual bands. When assayed on 
Golgi-enriched fraction (lanes 2 and 3), p210 affinity-purified im- 
munoglobulins reacted only with the 210-kD band (lane 2) whereas 
reactive pattern was indeed expected with an autoimmune 
serum, and in order to ascertain which of these bands cor- 
responded to the Golgi autoantigen, we turned to human 
lymphoblasts from the KE37 cell line, which provided us, 
in a reproducible manner, with a Golgi-enriched fraction 
prepared by flotation on a sucrose gradient (see Rios et al., 
1992). Total homogenate, nuclear pellet, postnuclear super- 
natant (75 #g), and Golgi-enriched fraction (50 #g) were in- 
dependently examined for their content in Golgi membranes 
by Western blotting, using an afffinity-purified anti-GalTf an- 
tibody (Fig. 3 B): only the Golgi-enriched fraction con- 
tained detectable amounts of GalTf. An identical nitrocellu- 
lose filter was incubated with RM serum (Fig. 3 C). Reactive 
bands with apparent molecular masses of 200, 130, and 45 
kD were the major components detected in the nuclear pellet 
or in the postnuclear supernatant of KE37 cells. However, 
a different pattern was observed in Golgi-enriched fractions: 
a 210-kD protein, that sometimes appeared as a doublet, was 
highly reactive (Fig. 3 C). These results strongly suggested 
that the 210-kD band was the Golgi autoantigen. Definitive 
demonstration of this was obtained by affinity purifying RM 
serum on individual reactive bands after electrophoretic 
separation and transfer onto nitrocellulose filters (Fig. 3 D). 
As a source of antigens, we used a membrane-enriched frac- 
tion obtained by high-speed centrifugation of the postnuclear 
supernatant: the 210- and the 130-kD bands were highly en- 
riched in this pellet and were the only reactive bands with 
RM serum (Fig. 3 D, lane/ ) ,  the 45-kD band turning out 
to be soluble (not shown). Antibodies retro-eluted from each 
band were further tested on a Golgi-enriched fraction: the 
210-kD band was revealed by p210 affinity-purified antibod- 
ies (Fig. 3 D, lane 2) whereas the p130 affinity-purified anti- 
bodies did not reveal any component in this fraction (Fig. 
3 D, lane 3) although it revealed the p130 in the membrane- 
enriched postnuclear fraction (not shown). Moreover, when 
assayed by immunofluorescence, p210 affinity-purified anti- 
bodies produced a strong Golgi staining pattern on HeLa 
cells (Fig. 3 E), whereas p130 affinity-purified antibodies 
did not give any Golgi staining nor any obvious other mem- 
brane compartment (not shown). 
Finally, proteins from the Golgi-enriched fraction were 
resolved by two-dimensional electrophoresis and were either 
stained with silver nitrate or transferred to nitrocellulose 
filters and incubated with the autoimmune serum (Fig. 4). 
The serum recognized one spot of molecular mass >200 kD 
and pI 5.6 (Fig. 4 A) which corresponded to an abundant pro- 
tein in silver-stained gels (Fig. 4 B). 
The 210-kD Protein Is a Peripheral Membrane Protein 
The membrane localization of the 210-kD protein was inves- 
tigated by using different extraction procedures. Isolated 
Golgi membranes (50 #g) were extracted with 2 % Triton 
X-114 (the most commonly employed method for separating 
hydrophilic and hydrophobic proteins) or washed with 6 M 
the pl30 affinity-purified immunoglobulins did not reveal any band 
(lane 3). The MW markers were stained by Ponceau red S. (E) 
p2 l0 affinity-purified immunoglobulins revealed the GA when used 
for immunofluorescence on HeLa cells after methanol fixation. 
Bar, 10 #m. 
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Figure 4. The Golgi-enriched fraction was resolved by two- 
dimensional electrophoresis. Two-dimensional gels were either 
transferred to nitrocellulose filters and incubated with autoimmune 
RM serum (.4) or stained with silver nitrate (B). Autoimmune RM 
serum recognized a spot of molecular mass 210 kD and pI 5.6. 
urea, 1 M NaC1, and 0.2 M sodium carbonate, pH 11.0. Su- 
pernatants and pellets of different treatments and aqueous 
and detergent phases of  Triton X-114 extraction were ana- 
lyzed by SDS-PAGE and transferred to nitrocellulose filters. 
The upper halves of  filters were processed for immunolabel- 
ing with RM serum (Fig. 5 A). The lower halves of  Western 
blots were immunolabeled with anti-GalTf antibody to mon- 
itor the different extraction procedures (Fig. 5 B). GalTf is 
an integral membrane protein disposed at the luminal face 
of  the trans cisternae. As expected, GalTf remained as- 
sociated to membranes after high salt, high pH, and urea 
treatments and partitioned in the detergent phase of Triton 
X-114 extraction. In contrast, the 210-kD protein entirely 
partitioned in the aqueous phase of  Triton X-114 extraction 
and became soluble upon all other treatments, indicating that 
Figure 5. p210 is an external and peripheral protein in Golgi mem- 
branes. Golgi membranes were treated with 2% Triton X-I14 (TX- 
114) as described by Bordier et ai. (1981) and both the aqueous 
(Aqu) and detergent (Det) phases were separated by SDS-PAGE and 
transferred to nitrocellulose filters. Other Golgi membranes were 
treated with 6 M urea, 1 M NaCI, and 200 mM sodium carbonate 
(pH 11.0), and after centrifugation, the resulting supernatants (S) 
and pellets (P) were processed as described above. The upper half 
of the filter was assayed by immunoblotting to detect p210 (A) and 
the lower half was incubated with anti-GalTf antibody as a control 
for a Golgi integral membrane protein (B). (C-F) HeLa cells were 
permeabilized using 0.5 U/m1 SLO for 7 min at 37°C and then in- 
cubated for I h with either autoimmune RM serum (C) or the anti- 
GalTf antibody (E). After washes, permeabilized cells were fixed 
and stained for GalTf (D) or p210 (F), respectively. No staining 
of the GA was observed in permeabilized cells incubated with anti- 
GalTf indicating that Golgi membranes remained intact after per- 
meabilization treatment. Bar, 5 gm. 
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p210 protein is a peripheral cytoplasmically disposed mem- 
brane protein. 
A different approach was also undertaken to confirm the 
localization of p210 in Golgi membranes. Semi-intact Hela 
cells were prepared using the bacterial toxin SLO to selec- 
tively permeabilize the plasma membrane to allow the access 
of antibodies to cytoplasm while maintaining the morpho- 
logical integrity of the GA. In addition, in cells perforated 
with SLO, the GA and most intracellular organelles were 
shown to be well preserved at light and electron microscopic 
level (Miller and Moore, 1991). 
HeLa cells were incubated with 0.2-2 U/ml SLO for 5-10 
min at 37°C, washed, and incubated with RM serum for 1 h. 
Then, cells were washed, fixed, and stained for GalTf. Anti- 
bodies bound before and after fixation were visualized using 
fluorescein and rhodamine secondary antibodies, respec- 
tively (Fig. 5, C and D). Treatment with 0.5 U/ml SLO for 
7 min at 37°C gave the best results: more than 80% of the 
cells were permeabilized and showed Golgi staining after in- 
cubation with RM serum for 1 h (Fig. 5 C). By contrast, no 
GA staining was observed in permeabilized cells incubated 
with anti-GalTf antibody before fixation (Fig. 5 E), indicat- 
ing that the GA itself was not perforated by SLO and re- 
mained impermeant to antibody molecules. 
p210 Is Concentrated at the Cis Side of the GA 
In an attempt to localize p210 at the ultrastructural level, we 
made use principally of primary cultures obtained from hu- 
man muscle biopsies that are capable of producing in vitro 
myogenesis. Although this system was not tractable for im- 
munoelectron cryomicroscopy, therefore imposing localiza- 
tion by immuno-peroxidase technique, it had two significant 
advantages: (a) it provided us with mononucleated cells dis- 
playing a highly extended GA; it was in these cells that RM 
serum decorated the GA with the most granular aspect (see 
Fig. 1, C and C'), suggesting that one could hopefully iden- 
tify the reactive structures within the GA; and (b) the GA in 
differentiating myotubes displays a characteristic perinuclear 
distribution, in which the cis-trans polarity is easily iden- 
tifiable from the nuclear periphery towards the plasma mem- 
brane (Tassin et al., 1985b). 
In mononucleated cells p210 demonstrated a clear asym- 
metrical distribution on one side of the GA (Fig. 6), the 
labeling being externally associated with budding or tubular 
processes in zones which, from their aspect, could cor- 
respond to the so-called "non-compact zones" described by 
Rambourg and Clermont (1990) (Fig. 6, A and B, curved ar- 
rows). Another constant feature was that face views of Golgi 
membranes demonstrated a discontinuous appearance of the 
labeling, corresponding to more or less regularly spaced 
small cavities (Fig. 6 A, straight arrows), which could cor- 
respond to the granular aspect observed at the optical level. 
Higher magnification suggested that these cavities cor- 
responded to large perforations of the saccules of the mid 
compartment described as "wells" by Rambourg and Cler- 
mont (1990) in the so-called "compact zones" of the GA. A 
face and a side view from the same Golgi area are indicated 
in Fig. 6 B (straight arrows). 
By immunofluorescence microscopy, young myotubes 
were decorated by RM serum in a manner strikingly similar 
to that obtained with any Golgi marker, i.e., essentially as 
a perinuclear ring (Fig. 7 A; for comparison see Tassin et al., 
1985b). One could, however, observe a rather punctuated as- 
pect of the perinuclear GA when decorated with RM serum 
(Fig. 7A, arrows). Ultrastructural localization demonstrated 
that p210 was associated with tubulovesicular structures at 
the cis side of the GA, and next to the nuclear envelope, 
which could penetrate deeply between saccules, the precipi- 
tate being detected between the lateral sides of the Golgi 
stacks. In these perforations, the labeling appeared abundant 
at the edge of the cisternae (Fig. 7 C, arrows). 
Overall, despite the difficulty of precisely deciding the ex- 
tent of the peroxidase labeling, the observation of numerous 
sections led us to conclude that p210 could interact with the 
external side of an abundant tubulovesicular system on the 
cis side of the Golgi, and that this system could encompass, 
or extend to, connecting structures or vesicles between in- 
dividual saccules and dictyosomes. 
p210 Redistributes in the Intermediate Compartment 
upon BFA Treatment 
BFA treatment of cells results in the rapid loss of the Golgi 
as a distinct organelle due to the redistribution of Golgi con- 
tent and membranes into the ER. Double immunofluores- 
cence staining with RM serum and with the trans-Golgi 
marker GalTf was performed on BFA-treated HeLa cells to 
determine the fate of p210. Within 5 min of BFA treatment 
(1 pg/ml), tubular processes extending out of enlarged Golgi 
structures were visible with the anti-GalTf antibody (Fig. 8 
B). RM serum showed a similar pattern although the tubular 
extensions were less evident (Fig. 8 A). After 30 rain of BFA 
treatment, in most cells GalTf was redistributed in a fine re- 
ticular pattern characteristic of ER labeling (Fig. 8 D). By 
contrast, p210 was present in numerous small vesicles scat- 
tered throughout the cytoplasm (Fig. 8 C), a pattern that re- 
mained unchanged upon longer incubations with BFA. Un- 
der these conditions the staining patterns displayed by GalTf 
and p210 were completely distinct whereas they were con- 
gruent in control cells. 
The effect of BFA on p210 was entirely reversible. HeLa 
cells treated with BFA for 1 h were allowed to recover during 
10 or 30 min in BFA-free medium. 10 min after removal of 
the drug, p210-containing vesicles appeared larger and tubu- 
lar structures extending towards a perinuclear region could 
be observed (Fig. 8 E). After 30 min of recovery, the spotty 
staining was greatly reduced and p210 was concentrated in 
a compact structure close to the nucleus (Fig. 8 G). The 
relocalization of GalTf was significantly slower although 
some vesicles could be observed 10 rain after removal of the 
drug (Fig. 8 F). These vesicles always colocalized with 
p210-containing elements, suggesting that movement of pro- 
teins out of the ER to the GA occurred through these ele- 
ments. After 30 min of BFA recovery, both proteins colocal- 
ized again (Fig. 8 H). The time course of the relocalization 
of both proteins strongly suggested that p210 elements were 
involved in the repositioning of the Golgi complex after 
removal of BFA, a possibility which would fit with the local- 
ization of p210 in the CGN. 
Until now, three proteins have been described to exhibit 
a similar staining pattern after BFA treatment: p58 (Saraste 
and Svensson, 1991), p53 (Lippincott-Schwartz et al., 1990), 
and p23 (Luen Tang et al., 1993), all of which reside in the 
intermediate compartment. To determine the nature of the 
spotty staining displayed by p210, we compared the localiza- 
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Figure 6. Ultrastructural localization of p210 in mononucleated cells from human myogenic cultures, using indirect immunoperoxidase 
techniques. At low magnification (A), the (3A displays a large spatial extension on one side of the nucleus (the nuclear envelope is indicated 
in A, NE) and surrounds the centrosome (the two centrioles are indicated in A, C). Side views of the Golgi elements demonstrate that 
p210 is associated with one side of the GA, where particularly tubular membrane extensions, or vesicles, appear labeled (curved arrows). 
Face views demonstrate numerous and rather even-spaced spots of regular size (straight arrows) which look like cavities. On higher 
magnification (B), and although ultrathin sections do not allow one to easily appreciate the overall architecture of the GA, one can recognize 
such cavities on face view (horizontal straight arrow) and tentatively identify them on side views (vertical straight arrow). They apparently 
correspond to perforations in register, or wells, which often interrupt the mid saccules (Rambourg and Clermont, 1990) and their decoration 
by RM serum could be responsible for the granular aspect of immunofluorescent staining at the light level (see Fig. 1). Curved arrows 
in B point to labeled budding elements. 






Figure 7. Immunolocalization of p210 in myotubes from human myogenic cultures. (A) Immunofluorescent staining. RM serum decorates 
the periphery of the syncytium nuclei, and some elements within the cytoplasm, in a manner strikingly similar to what is observed with 
bona fide Golgi markers (see Tassin et ai., 1985b). Note however that the perinuclear staining, when in focus, appears patchy (arrows), 
a feature which was not observed with other markers of the Golgl. (B and C) Two magnifications of the ultrastructural localization of 
p210 in the Perinuclear GA, using indirect immunoperoxidase techniques. They demonstrate unambiguously that p210 is on the nuclear 
side of the GA, which has been previously demonstrated to be the cis side (Tassin et al., 1985b). The labeling apparently concerns an 
abundant tubulo-vesicular system on the cis side of the Golgi saccules proper, but can also Penetrate into zones where saccules are inter- 
rupted (C, arrows). The last feature is probably responsible for the patchy aspect of the perinuclear staining observed by immunofluores- 
cence (A, arrows). The low magnification in B corresponds to the same nucleus for which most of the chromatin has been deleted on 
the picture for the sake of space. 
tion of p58 and p210 in control conditions and after BFA 
treatment. As shown in the double label immunofluorescence 
experiment in Fig. 9, p58 showed a larger distribution than 
p210 in both myoblasts (Fig. 9, A and B) and HeLa cells (Fig. 
9, C and D): codistribution of p58 and p210 was restricted 
to the Golgi structure (Fig. 9, A and B, arrows), but vesicular 
elements decorated by p58 were observed outside the Golgi 
region in both cell types. By contrast, upon incubation of 
cells with BFA for 1 h, both p210 and p58 were apparently 
present in the same structures (Fig. 9, E and F). Incubations 
of cells for 90 rain at 16 ° did not modify the Golgi staining 
pattern exhibited by p210 although tubules emerging from 
the Golgi region are sometimes visible with the RM serum 
(Rios, R. M., and M. Bornens, manuscript in preparation). 
From these observations, we could conclude that, rather 
than being a resident protein of the intermediate compart- 
ment such as p58 (Saraste and Svensson, 1991), p210 is a 
Golgi protein which is induced to redistribute in the inter- 
mediate compartment by BFA. To clearly demonstrate that 
BFA-induced p210-containing vesicles corresponded to the 
intermediate compartment, we took advantage of the find- 
ings of Lippincott-Schwartz et al. (1990) who reported that 
the intermediate compartment remains intact in BFA-treated 
cells, the Golgi resident proteins cycling continuously, in a 
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Figure 8. Immunofluorescence local- 
ization of p210 in BFA-treated cells. 
(A-D) HeLa cells were incubated with 
BFA (1 #g/ml) for 5 (A and B) or 30 
min (C and D) at 37°C before fixation 
and dual immunofluorescenee staining 
with autoimmune RM serum (A and 
C) or anti-GalTf (B and D). Treatment 
of cells with BFA for 5 min caused the 
cisternae to enlarge and to extend thin 
tubular processes out from the Golgi 
region. At this time, the p210 protein 
still overlapped with GalTf. After 30 
min of treatment, p210 and GalTf were 
no longer codistributed. GalTf showed 
a reticular staining characteristic of 
ER redistribution whereas p210 ap- 
peared in numerous vesicles scattered 
throughout the cytoplasm. (E-H) Al- 
ternatively, HeLa ceils were incubated 
for 2 h with BFA and then chased in 
fresh, untreated medium for 10 (E and 
F) or 30 min (G and H) to allow recov- 
ery from BFA treatment. The cells 
were then fixed and labeled for p210 
and GalTf. Note the faster reorganiza- 
tion of the vesicular elements contain- 
ing p210 as compared with GalTf and 
the extension of tubular processes 
from these elements. Bar, 5 tzm. 
microtubule-dependent manner, between ER and this com- 
partment. HeLa cells incubated with 1 #g/ml BFA for 1 h 
(Fig. 10, A and B) and further with BFA plus 10 #M nocoda- 
zole for 2 h (Fig. 10, Cand D) were double stained for p210 
and GalTf. Whereas GalTf was localized in a reticular pat- 
tern in BFA-treated ceils (Fig. 10 B), it appeared in some of 
the vesicular structures containing p210 after incubation 
with BFA plus nocodazole (compare Fig. 10, B and D). 
These vesicles were significantly larger than those observed 
in cells treated with BFA alone (compare (Fig. 10, A and C) 
probably due to the accumulation of Golgi proteins, such as 
GalTf, moving out of the ER and incapable of returning to 
the ER. 
This effect was indeed dramatically enhanced when BFA- 
treated cells were incubated" with the calcium ionophore 
A23187 (Fig. 11), an agent that has been reported to stimu- 
late the secretion of ER-resident proteins by perturbing the 
normal sorting system (Booth and Koch, 1989). Addition of 
ionophore A23187 to cells modified the morphology of nei- 
ther the Golgi apparatus (Fig. 11, A and B) nor the ER 
visualized using an ER-specific antibody (Fig. 11 C). The 
microtubule network also remained intact under these condi- 
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Figure 9. Double immunofluorescence staining of human myoblasts (A and B) and HeLa cells (C and D) with autoimmtme RM serum 
(A and C) and p58, a marker of the intermediate compartment (B and D). In both cell types, p58-stained Golgi complex (A and B, arrows) 
and a number of vesicles dispersed throughout the cytoplasm whereas p210 only decorated the GA. After incubation of cells with BFA 
for 1 h (E and F), both proteins seem to colocalize in the same vesicular structures. Bar, 5/zm. 
tions (not shown). Treatment of cells with BFA followed by 
BFA plus ionophore A23187 caused the same effect as treat- 
ment with BFA plus nocodazole: GalTf accumulated in the 
vesicles labeled with p210 (Fig. 11, D and E). In these condi- 
tions, the ER appeared fragmented (Fig. 11 F). If, in addi- 
tion, nocodazole was added, practically all GalTf was absent 
from the ER and appeared in large structures that contained 
p210 (Fig. 11, G and H). The effect of nocodazole was not 
apparently modified by ionophore A23187 and all microtu- 
bules became depolymerized (Fig. 11, I and L). Remarkably, 
the staining patterns of GalTf and p210 in these conditions 
were completely coincident. Moreover, ER-resident proteins 
also appeared to be induced to exit the ER in these conditions 
as they accumulated in p210-containing vesicles (Fig. 11, J 
and K). These observations support and extend those re- 
ported by Lippincott-Schwartz et al. (1990) concerning the 
movement of proteins out of ER in the presence of BFA. 
D i s c u s s i o n  
Many studies have now shown that human autoantibodies 
recognize highly conserved antigenic determinants that usu- 
ally correspond to functionally important domains on mole- 
cules. RM serum, a Sj6gren's syndrome serum, showed a 
very high reactivity to the Golgi complex in a wide variety 
of cells. Circulating autoantibodies reacting against the 
Golgi complex have been previously described (Rodriguez 
et al., 1982; Fritzler et al., 1984; Blaschek et al., 1988; 
Gaspar et al., 1988) but autoantigens were not further inves- 
tigated. Only one Golgi autoantigen, a protein of molecular 
mass 230 kD has been recently identified and associated with 
the trans face of the GA (Kooy et al., 1992). 
RM serum allowed us to identify a novel Golgi protein 
designated as p210, which might be highly conserved, as RM 
serum decorates the GA in many species, including pri- 
mates, rodents, and amphibians. The high reactivity and 
specificity exhibited by RM serum in immunofluorescence 
experiments led us first to attempt to identify the Golgi au- 
toantigen by immunoprecipitation of total cellular extracts. 
We found, however, that RM serum immunoprecipitated a 
range of cellular antigens from 45 to 230 kD indicating that 
multiple autoreactivities were present in the serum. This 
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Figure 10. Effect of nocodazole 
on the distribution of p210 and 
GalTf in BFA-treated cells. 
HeLa cells were treated with 
BFA for 1 h (A and B) or with 
BFA for 1 h and then BFA plus 
nocodazole for 2 h (C and D). 
These cells were then fixed 
and stained for immunofluores- 
cence microscopy using anti- 
bodies against p210 (A and C) 
and GalTf (B and D). Upon ad- 
dition of nocodazole to BFA- 
treated cells, the staining pat- 
tern of GalTf redistributed from 
a fine reticular pattern char- 
acteristic of ER labeling into 
larger vesicles that contained 
p210 (C and D, arrows). Bar, 
5 #m. 
diversity of autoantibody species is a common characteristic 
of autoimmune diseases (Tan, 1991). The Golgi autoantigen 
recognized by RM serum was identified as a component with 
an apparent molecular mass of 210 kD based on two observa- 
tions: (a) the 210-kD band was highly enriched and was the 
only reactive one detected in a subcellular fraction rich in 
Golgi membranes; and (b) only the antibodies affinity 
purified on this band decorated the Golgi apparatus by im- 
munofluorescence. The other bands detected by Western blot 
or by immunoprecipitation must be recognized by distinct 
autoantibodies present in the serum. 
The p210 protein was shown to be a peripheral cytoplas- 
micaUy disposed membrane protein by two criteria. It parti- 
tioned into the aqueous phase on extraction with Triton-X114 
and was removed from the membranes by washing with urea, 
sodium carbonate, and NaCI. Furthermore, p210 was acces- 
sible to autoantibodies from the cytoplasm in conditions in 
which integrity of Golgi membranes was retained. Im- 
munoperoxidase labeling at electron microscopic level using 
differentiating human myoblast culture confirmed the pe- 
ripheral cytoplasmically disposed membrane location of the 
p210. The fenestrated appearance of membranes labeled 
with p210 in both myoblasts and myotubes, analogous to a 
tubular network, suggests that these structures correspond to 
the CGN. That p210 decorated tubulovesicular structures 
close to the nuclear envelope in myotubes unequivocally es- 
tablished that p210 associates with the cis side of the Golgi 
complex. Interestingly, p210 labeling in myotubes was ob- 
served at the rims of some cisternae more distal to the nu- 
clear envelope (probably the cis cisternae of the medial- 
Golgi complex) and even at membrane regions where buds 
seem to emerge. Face views of the Golgi membranes in myo- 
blasts which demonstrated accumulation of labeling into 
rather regularly spaced wells (see Fig. 7) were consistent 
with this possibility. They also give an interpretation for the 
granular immunofluorescence pattern of p210 observed in 
myotubes, myoblasts, HeLa cells, and many other cell types 
(not shown): such a granular appearance reflects discontinu- 
ous accumulation of the antigen. Taken together, the data are 
consistent with the possibility that p210 could interact with 
the external side of an abundant tubulovesicular system on 
the cis side of the Golgi complex, corresponding to the 
CGN. This network appeared to encompass, or extend to, 
a subset of vesicular elements within the wells which inter- 
rupt the saccules of the mid compartment (in the so-called 
compact zones) and connecting structures between individ- 
ual dictyosomes (in the so-called non-compact zones). This 
conclusion is also supported by the intriguing behavior of 
p210 after microtubule disruption, namely its partial segre- 
gation from Golgi markers. 
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Figure 11. Effect of the calcium ionophore A23187 and nocodazole on the relocalization of both Golgi and ER proteins from ER to p210- 
containing elements in BFA-treatexl cells. (A-C) HeLa cells were incubated for 4 h with 5/~M A23187 and then fixed and stained for 
p210 (A), GalTf (B), or an ER-resident protein (C). No changes in the morphology of the Golgi apparatus or the Eli were detected. (D-L) 
Alternatively, cells were incubated with BFA for 1 h and then for 4 h with either the calcium ionophore A23187 (D-F) or the calcium 
ionophore plus nocodazole (G-L) in BFA-containing medium. Cells treated with BFA and then with BFA plus ionophore A23187 were 
double stained with autoimmune RM serum (D) and anti-GalTf antibody (E). As can be seen, ionophore A23187 induced the exit of GalTf 
from the ER and its accumulation in vesicles labeled with p210 (arrows). Morphology of the ER in these conditions was also examined 
(F). In similar experiments, cells were treated with BFA and then with ionophore A23187 plus nocodazole in the presence of BFA in order 
to induce the exit of proteins from the ER and to block their returning to the ER. Cells were double stained for p210 (G) and GalTf (H) 
or for p210 (J) and an ER-resident protein (K). As expected, ionophore A23187 did not affect the microtubule depolymerization caused 
by nocodazole (I-L). Note that in these conditions, part of the ER proteins themselves accumulate in p210-containing vesicles (J-K, ar- 
rows). Bar, 5 ~m. 






In many cellular systems, nocodazole induces the breaking 
of the Golgi complex into hundred of fragments distributed 
throughout the cytoplasm, and electron microscopic exami- 
nation has revealed that the fragments are composed of 
stacked cisternae that maintain their original organization 
(dictyosomes) (Robbins and Gonatas, 1964; Pavelka and El- 
linger, 1983; Thyberg and Moskalewski, 1985; Turner and 
Tartakoff, 1989). Despite the fragmentation of the GA cellu- 
lar secretory and biosynthetic activities are remarkably un- 
affected (Rogalski and Singer, 1984; Rogalski et al., 1984). 
In immunofluorescence experiments, proteins distributed in 
different cisternae of the Golgi complex colocalize in the 
same fragments after disruption of microtubules by drugs 
(Yuang et al., 1987; Turner and Tartakoff, 1989). On the 
other hand, proteins, such as p58 or p53, residing in the in- 
termediate compartment, show, in untreated cells, a distribu- 
tion distinct from that of Golgi markers. It was therefore sur- 
prising that p210 segregated from medial and trans markers 
in nocodazole-treated cells, whereas the staining patterns 
were coincident in control conditions. Moreover, this segre- 
gation started quite early after nocodazole addition (5-15 
min), indicating that p210-specific elements were specially 
sensitive to microtubule disruption. 
The Golgi complex is normally composed of stacks of 
cisternae interconnected by tubular structures that have been 
named intersaccular connections (Rambourg and Clermont, 
1990). Using NBD-ceramide, Cooper et al. (1990) showed 
that Golgi cisternae extend tubulovesicular processes along 
microtubules which form stable contacts with the mem- 
branes of adjacent Golgi elements producing the fusion of 
the cisternae into a continuous reticulum. It has been pro- 
posed that these tubular connections are severed after 
microtubule depolymerization leading to dispersal of in- 
dividual stacks (Tassin et al., 1985b). Turner and Tartakoff 
(1989) analyzed the dispersal of the GA and distinguished 
three steps: (a) microtubule depolymerization, (b) Golgi 
fragmentation (30-60 min), and (c) fragment dispersal (120 
rain). Disruption of microtubules could produce the vesicu- 
larization of the tubular microtubule-dependent intersaccu- 
lar connections before the fragmentation process became ap- 
parent. In our opinion, the results on p210 distribution in 
nocodazole-treated cells suggest that this protein might be 
localized both in dictyosomes, in which it associates with the 
CGN, and in tubular connections which are stabilized by 
microtubules, a possibility which agrees with the heteroge- 
neous staining displayed by RM serum. If this is true, most 
of the Golgi proteins would be excluded from these intercon- 
necting tubules since proteins exhibiting this behavior have 
not been described. 
Alternatively, since p210 seems to be associated with the 
whole CGN, it is possible that among the vesicles observed 
after short treatments with nocodazole, many arise by frag- 
mentation of tubules emanating from this network. If so, it 
would mean that the CGN itself is also stabilized by microtu- 
bules. 
Also surprising was the finding that p210 did not redistrib- 
ute in the ER in the presence of BFA. On the contrary, it ap- 
peared in vesicular elements dispersed throughout the cyto- 
plasm. This result led us to consider whether p210 could be 
a resident protein of the intermediate compartment like p58 
or p53. Double labeling using p58 as a marker confirmed 
that p210 is primarily bound to the Golgi complex itself 
rather than to the intermediate compartment. After treat- 
ment of cells with BFA, however, p58 and p210 colocaiized. 
We confirmed the identity of the vesicular elements contain- 
ing p58 and p210 by using drugs that have been reported to 
block the retrograde transport from the intermediate com- 
partment to the ER such as nocodazole, to stimulate the exit 
of proteins from ER such as calcium ionophores, or both. 
Our results are in agreement with those reported previously 
indicating that (a) a cycling pathway between the ER and the 
intermediate compartment occurs in the presence of BFA 
(Lippincott-Schwartz et al., 1990); (b) the retrograde side of 
the cycling pathway is inhibited by microtubule disruption 
(Lippincott-Schwartz et al., 1990); and (c) calcium iono- 
phores induce proteins to escape from the ER (Booth and 
Koch, 1989). Combination of both treatments in the pres- 
ence of BFA results in the depletion of Golgi proteins from 
the ER and their accumulation in the intermediate cOmpart- 
ment. Resident proteins of ER themselves also accumulated 
in these structures. These results indicate that p210 is a cis- 
Golgi protein (probably a CGN marker) that redistributes in 
the intermediate compartment by effect of BFA. Some Golgi 
proteins, p210 at least, can be excluded from the BFA- 
induced pathway that carries the Golgi membranes to the ER 
and suggest the existence of mechanisms that retain spe- 
cifically certain proteins in the intermediate compartment. 
Studying the p210 behavior, it appears clear however that 
p210-associated structures are involved in the reassembly of 
the GA following its disruption by BFA. Within minutes of 
removing the drug, the Golgi markers move out of the ER 
into peripheral intermediate compartment sites (Lippincott- 
Schwartz et al., 1990; Alcalde et al., 1992). Ifmicrotubules 
are disrupted during removal of BFA, Golgi structures that 
can secrete proteins remain localized in these peripheral in- 
termediate compartment sites (Lippincott-Schwartz, 1993; 
Alcalde et al., 1992). Biogenesis of the Golgi complex in- 
volves, therefore, both the intermediate compartment and 
microtubules. Our results on the recovery of BFA-treated 
cells are consistent with this scheme. Shortly after removing 
BFA, tubules containing p210 extended from these inter- 
mediate compartment elements and seemed to converge to 
a perinuclear position. At that moment, medial markers (not 
shown) and trans-Golgi markers (Fig. 8, E and F) began to 
accumulate into some peripheral p210-containing vesicles. 
Formation at 16°C of membrane tubules that contained 
p53 has been previously reported but resident Golgi proteins 
appeared to be excluded from these tubular processes 
(Lippincott-Schwartz et al., 1990; Hauri and Schweizer, 
1992). Addition of BFA resulted in the movement of Golgi 
proteins into the p53-containing tubules. These observations 
have led to the view that these tubular processes function un- 
der both normal conditions and BFA treatment and that BFA 
could interfere with the mechanism that restricts entry of 
membrane proteins into the retrograde tubules. Available 
data support a role of tubular membrane structures in the 
retrograde transport under both normal conditions and BFA, 
in the reorganization and repositioning of the Golgi complex 
after removal of BFA and in connecting homologous cister- 
nae of different stacks or even different cisternae of the same 
stack (Klausner et al., 1992; Mellman and Simons, 1992; 
Lippincott-Schwartz, 1993). We have detected the presence 
of p210, a resident Golgi protein, in membrane tubules which 
form at 160C (Rios, R. M., and M. Bornens, manuscript in 
Rios et al. A Novel 210-kD cis-Golgi Network-associated Protein 1011 






preparation) and in those which mediate the reconstruction 
of the GA after BFA treatment (this work). In addition, p210 
appears to be associated with the CGN, a tubular-cisternal 
network, and presumably with tubules connecting different 
Golgi stacks. From these results there emerges a relation of 
this protein with the formation of microtubule-dependent 
membrane tubules or with processes mediated by them. Since 
human autoantibodies are usually capable of inhibiting the 
functional activity of the antigens, the permeabilization ex- 
periments used in this work (Fig. 5) represent a first step to 
directly examine the function of p210 in the cell. Preliminary 
data from this type of functional study using SLO-per- 
meabilized cells have revealed that RM immunoglobulins 
block nocodazole-induced fragmentation of the GA, possi- 
bly by stabilizing membrane tubules connecting different 
Golgi stacks. In addition, p210 was found to be enriched in 
preparations of Taxol-induced microtubules from KE37 and 
HeLa cells (Rios, R. M., and M. Bornens, unpublished re- 
suits). The possibility of a direct interaction of p210 with 
microtubules is now being investigated. This would well 
agree with the fact that this protein is peripheral. Moreover, 
together with the behavior of p210 during BFA treatment, 
this fits nicely with the known involvement of the intermedi- 
ate compartment and microtubules in the biogenesis of the 
Golgi complex after BFA treatment. 
We have shown that p210 cycles between the CGN and the 
intermediate compartment by effect of BFA. Does p210 cycle 
similarly under normal conditions? Although more experi- 
ments are necessary, our preliminary data showing localiza- 
tion of p210 in tubules that emanate from the Golgi complex 
at 16°C would suggest that it does. In that case, it must be 
rapidly recycled to the CGN since we have been unable to 
detect it in the intermediate compartment. Therefore, the in- 
termediate compartment could serve to recycle not only pro- 
teins moving out from ER but also from the GA to their 
original locations. 
Three other autoantigens have been previously reported to 
be associated with the Sj6gren's syndrome: a component of 
ribonucleoprotein particles of mol wt 60,000, a 48-kD pro- 
tein that associates to nascent transcript (Tan, 1991), and a 
p230 localized in the Golgi complex (Kooy et al., 1992). 
This p230 Golgi protein exhibits some characteristics simi- 
lar to our p210 autoantigen, but also some marked differ- 
ences: first, the p230 is associated with the t rans  cisternae 
of the GA, and second, BFA induces the dissociation of p230 
from the Golgi complex to cytosol. A 200-kD Golgi protein 
has also been reported by Narula et al. (1992). This protein 
is not cisternae specific but accumulates to dilated rims o f  
cisternae and on vesicles scattered in the Golgi region. Like 
p230, p200 redistributes in the cytoplasm upon BFA action, 
but both proteins differ in the kinetics of BFA action. 
In conclusion, p210 appears to be a novel Golgi protein 
which might be a useful marker in deciphering the dynamics 
of the ER-Golgi pathway. Morphological criteria have 
demonstrated that p53 and p58 cycle constitutively between 
the ER, the intermediate compartment, and the CGN. This 
dynamic behavior together with the lack of a marker for the 
CGN has hindered the comprehension of structural and 
functional relationships between these three membrane- 
bound compartments. Recently, a novel protein, p63, that re- 
sides in the intermediate compartment and does not cycle be- 
tween ER and the CGN has been identified (Schweizer et al., 
1993). Here, we have identified a protein residing in the 
CGN that cycles between this structure and the intermediate 
compartment, at least in the presence of BFA. We think that 
both proteins, p63 and p210, represent useful tools to clar- 
ify the intimate relationships between the intermediate com- 
partment and the GA. In addition, p210 might be an impor- 
tant protein for the microtubule-dependent organization of 
the GA. 
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